COMMUNIQUÉS West-GlobeNewswire

Nova Leap Health Corp. Announces Execution of Letter of Intent (LOI) to Acquire Home Care Services Business in the Northeastern U.S.

09/01/2018 - 15:02

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- NOVA [...]

Voluntis and WellDoc Announce Partnership to Combine Diabetes Digital Therapeutic Offerings

09/01/2018 - 15:00

CAMBRIDGE, Mass. and COLUMBIA, Md., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Voluntis and WellDoc®, two of the industry’s leading digital therapeutics companies, announced today a commercial agreement aimed at combining [...]

IlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss® Bone Stabilization System

09/01/2018 - 15:00

EAST PROVIDENCE, R.I., Jan. 09, 2018 (GLOBE NEWSWIRE) -- IlluminOss Medical , a privately held, commercial-stage medical device company focused on minimally invasive orthopedic fracture repair, today announced that it [...]

Tower One Offers Warrant Extension, Price Reduction and Exercise Incentive

09/01/2018 - 15:00

VANCOUVER, British Columbia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCMKTS:TOWTF) (FRANKFURT: A2DKQ4 ) (“Tower One” or the “Company ”) announces, further to its news release dated December [...]

BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab

09/01/2018 - 15:00

CAMBRIDGE, Mass., BEIJING and SHANGHAI, China, Jan. 09, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ) and Boehringer Ingelheim Biopharmaceuticals (China) Ltd. today announced that the two companies have entered [...]

Teladoc Announces Commercial Availability of Integrated Teladoc - Best Doctors Mobile App Experience

09/01/2018 - 14:35

PURCHASE, NY, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the world’s largest and most trusted provider of virtual care delivery services, announced today the commercial availability of its [...]

Histogenics Corporation Announces Receipt of $10 Million Up-front Payment for Japanese Neocart Agreement

09/01/2018 - 14:30

WALTHAM, Mass., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]

Spring Bank Strengthens Management Team to Enhance Operations

09/01/2018 - 14:30

Appoints Kevin Leach, Ph.D., as Vice President, Nonclinical & Translational Research Promotes Garrett Winslow to General Counsel HOPKINTON, Mass., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc [...]

Positive Results From a Multi-Center Analysis of Delcath PHP Therapy Published in Journal of Surgical Oncology

09/01/2018 - 14:30

NEW YORK, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that results of a multi- [...]

Hemispherx Announces Presentation of New-Found Properties of Ampligen at Immuno-Oncology Frontiers Conference, Jan 24

09/01/2018 - 14:30

ORLANDO, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused on pharmaceutical research, today announced that Pawel Kalinski, MD, PhD, Rustum Family Professor for Molecular [...]

Yield10 Bioscience Reports Encouraging Results from 2017 Field Tests of Novel Yield Trait Gene C3003 in Camelina and Canola

09/01/2018 - 14:30

WOBURN, Mass., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today reported encouraging results from the 2017 Field Tests of its novel yield trait gene C3003 in Camelina and canola. Yield10 [...]

Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results

09/01/2018 - 14:30

AUDUBON, Pa., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year [...]

Vystar Signs LOI to Acquire NHS Holdings

09/01/2018 - 14:30

Proposed purchase for $1.5 million an 85% discount from $5 million valuation NHS Introduced Vytex® into the Bedding Industry WORCESTER, Mass., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCPink:VYST) has [...]

United Health Products Gains Patent Protection Extension for HemoStyp®

09/01/2018 - 14:05

HENDERSON, Nev., Jan. 09, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTCPK:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]

New York Plastic Surgical Group Expands into Westchester

09/01/2018 - 14:01

GARDEN CITY, N.Y., Jan. 09, 2018 (GLOBE NEWSWIRE) -- New York Plastic Surgical Group , a division of Long Island Plastic Surgical Group (LIPSG), is pleased to announce the opening of a new office at 222 Westchester [...]

Crown Bioscience Launches CrownSyn™, an Innovative Bioinformatics Solution that Simplifies the Characterization of Two-Drug Combination Studies

09/01/2018 - 14:00

SAN DIEGO, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]

Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations

09/01/2018 - 14:00

Santa Monica, CA, Jan. 09, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

GBT Receives FDA Breakthrough Therapy Designation for Voxelotor for Treatment of Sickle Cell Disease (SCD)

09/01/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy [...]

Pain Therapeutics Reports Positive Top-line Results from Nasal Abuse Potential Study with REMOXY™

09/01/2018 - 14:00

- Study Meets Primary Endpoint (p<0.01) - - REMOXY NDA Remains On-Track for Resubmission in Q1 2018 - AUSTIN, Texas, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE ) today announced positive [...]